Company intelligence / Profile preview

Segra International

Richmond, British Columbia, Canadasegra-intl.com ↗

Ownership: Private
Employees: ~26
Development stage: Commercial

Overview

Segra International is a leading provider of industrial-scale cannabis micropropagation services, offering disease-free, genetically verified young plants to licensed producers. The company has developed proprietary technologies for DNA fingerprinting and pathogen detection in cannabis. It operates state-of-the-art facilities focused on research, development of IP related to tissue culture automation, genomics tools, bioinformatics systems, and marker-assisted selection breeding programs. No clinical results as it is not a drug developer.

Modalities: Plant tissue cultureMicropropagation
Industry: Agriculture & AgTech

Partnerships

Not explicitly listed; works with leading genetic providers in the cannabis industry.

Beyond the preview

Go deeper on Segra International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Segra International.

Explore the full profile